Cell-Penetrating Peptides: From Snake Venom to Drug Delivery — A Complete Guide

Narrative review synthesizing literature on CPP discovery, design innovations, and therapeutic applications. Covers the evolution from natural venom-derived CPPs through synthetic engineering approaches and their preclinical applications for peptide/protein drug delivery.

The biopharmaceutical industry increasingly relies on peptide and protein drugs, but their inability to cross cell membranes is a fundamental limitation. CPPs offer a solution that could unlock the therapeutic potential of biologics for intracellular targets — expanding the drug target landscape from cell-surface proteins to the entire proteome inside the cell.

Cell-penetrating peptides sit at the intersection of peptide science, drug delivery, and biopharmaceutical development. As the pharmaceutical industry shifts toward biologic drugs (peptides, proteins, antibodies, nucleic acids), the delivery challenge becomes paramount. CPPs offer a peptide-based solution to a peptide delivery problem — an elegant recursive approach. The field is maturing from academic curiosity to clinical pipeline, with several CPP-drug conjugates in clinical trials.

As a review, this paper does not present new experimental data. Most CPP applications discussed are preclinical. Clinical translation challenges (immunogenicity, off-target cell penetration, manufacturing scalability) are common across the field but may not be fully addressed. The review does not systematically compare CPP performance across different cargo types or disease models. Toxicity concerns with venom-derived CPPs at therapeutic doses need careful evaluation.